Surface markers, such as CD13, CD44, EpCAM, CD90, CD24, CD34, CD47, ICAM1, EpCAM, LGR5, and OV6, are widely recognized as markers of LCSCs, because of their association with proliferative capacity, self-renewal capacity, drug resistance, and recurrence of liver cancer. This evidence concerns the gene ANPEP and liver cancer.